Atriomx Health
Non-invasive arrhythmia detection and characterization platform.
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.0m | Series A | ||
| Total Funding | 000k | ||
Atriomx Health, founded in 2020 and based in Menlo Park, California, was a medical technology company focused on developing non-invasive solutions for cardiac arrhythmias. The company aimed to create a diagnostic platform using hardware, software, and advanced algorithms to detect and characterize the underlying mechanisms of atrial fibrillation (AFib) and other heart rhythm disorders. The technology was intended to provide physicians with deeper insights into a patient's specific disease state, enabling more informed treatment decisions.
The company secured $10 million in a Series A financing round in December 2020, co-led by Ajax Health and Zeus Health, a platform created by the investment firm KKR. The funding was allocated to support the initial development and clinical studies of its integrated solutions. In conjunction with the financing, Mike Carter, a founding engineer with a background in productizing advanced algorithms from Kodiak Robotics, was appointed as Chief Operating Officer. According to multiple business data platforms, the company appears to have ceased operations as of late 2022.
Keywords: cardiac arrhythmia, atrial fibrillation, non-invasive diagnostics, medical equipment, disease characterization, diagnostic algorithms, heart rhythm, AFib detection, arrhythmia monitoring, healthtech, diagnostic equipment, Ajax Health, Zeus Health